Summary
Researchers investigated the therapeutic mechanisms of Triphala in periodontitis, using network pharmacology and experimental validation in cellular and animal models. The study, led by Zhao et al., revealed that Triphala acts to reduce periodontal inflammation and promote tissue regeneration. The authors identified 15 main molecular targets, including growth factors and cytokines, which are involved in the inflammatory response. Furthermore, the analysis demonstrated that Triphala can modulate the expression of genes related to apoptosis and healing, suggesting a protective role in periodontal diseases. The results were obtained through in vitro and in vivo experiments, showing the efficacy of Triphala in controlled environments. Limitations include the need for more clinical studies to confirm these findings in humans.
Key points
- Triphala reduces periodontal inflammation by modulating inflammatory cytokines.
- Identification of 15 main molecular targets that influence the response to periodontitis.
- Evidence that Triphala promotes tissue regeneration in experimental models.
- Results obtained in in vitro and in vivo studies, but human clinical trials are lacking.
- Triphala's action on the expression of genes related to apoptosis and healing.
✦ For you
If you have concerns about oral health, consider including Triphala in your routine, whether in powder form or as mouthwash. Observe how your gums react and whether there is a reduction in inflammation. Additionally, maintain good oral hygiene and consult a dentist regularly. If symptoms persist, seek a qualified health professional.
For practitionersExpand
For therapists, the inclusion of Triphala (Terminalia chebula, Terminalia bellirica, Emblica officinalis) in periodontal treatment protocols can be beneficial. Evaluate the patient's response to therapy and consider adjustments to the formulation based on the severity of inflammation and observed tissue regeneration. Combining with oral hygiene practices can enhance results.